Intrathecal immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial
<p>Despite long-standing availability of an effective vaccine, tetanus remains a significant problem in many countries. Outcome depends on access to mechanical ventilation and intensive care facilities and in settings where these are limited, mortality remains high. Administration of tetanus a...
Main Authors: | Loan, H, Yen, L, Kestelyn, E, Hao, N, Thanh, T, Dung, N, Turner, H, Geskus, R, Wolbers, M, Tan, L, Van Doorn, H, Day, N, Wyncoll, D, Hien, T, Thwaites, G, Vinh Chau, N, Thwaites, C |
---|---|
Format: | Journal article |
Published: |
F1000Research
2018
|
Similar Items
-
Intrathecal Immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial
by: Loan, H, et al.
Published: (2018) -
A pilot study to assess safety and feasibility of Intrathecal Immunoglobulin for the treatment of adults with Tetanus
by: Loan, H, et al.
Published: (2018) -
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial
by: Van Hao, N, et al.
Published: (2022) -
Predicting the clinical outcome of tetanus: the tetanus severity score.
by: Thwaites, C, et al.
Published: (2006) -
Urinary catecholamine excretion, cardiovascular variability, and outcomes in tetanus
by: Du, DH, et al.
Published: (2023)